Multidrug chemotherapy, whole-brain radiation and cytarabine therapy for primary central nervous system lymphoma in elderly patients with dose modification based on geriatric assessment: study protocol for a phase II, multicentre, non-randomised study.
Fumiyuki YamasakiHirotaka FudabaKenichiro AsanoTakashi SasayamaManabu NatsumedaTaichi ShimabukuroKotaro TaguchiShinichiro KoizumiNoriyuki NakayamaKentaro FujiiIkuno NishibuchiKazuhiko SugiyamaKenji YoshidaUshio YonezawaMomii YasutomoYukari KawasakiKiyohide KakutaKosuke KatayamaKazuhiro TanakaHiroaki NagashimaYoshihiro TsukamotoMakoto IdeguchiTakafumi NishizakiKazuhiko KurozumiTomohiro HosoyaTomoyuki AkitaAtsushi KambePublished in: BMJ open (2023)
jRCTs061180093.
Keyphrases
- phase ii
- clinical trial
- open label
- double blind
- placebo controlled
- study protocol
- acute myeloid leukemia
- high dose
- phase iii
- drug resistant
- diffuse large b cell lymphoma
- white matter
- squamous cell carcinoma
- resting state
- cross sectional
- locally advanced
- middle aged
- randomized controlled trial
- subarachnoid hemorrhage
- brain injury
- multiple sclerosis